How much does Eliquis cost in Europe (and why the price varies)?
Eliquis (apixaban) prices across Europe are not set at a single, Europe-wide level. Costs vary by country because each market can apply different pricing rules, taxes, and reimbursement structures, and because Eliquis is sold in multiple strengths and pack sizes. As a result, there is no single “Europe price” you can rely on.
What’s the quickest way to find the current Eliquis price in your country?
The fastest approach is to check the specific country’s official price list or reimbursement information (since those reflect the pharmacy price and/or the amount patients pay after insurance). If you tell me which European country you mean (for example, UK, Germany, France, Spain, Italy, Netherlands, etc.) and the Eliquis dose (2.5 mg or 5 mg) and pack size if you know it, I can help you pinpoint what to look for and how to interpret it.
Do you mean the price patients pay or the pharmacy list price?
In many European countries, the “cost” you’ll see online may mean either:
- the pharmacy retail/list price, or
- the reimbursed price (and your copay after reimbursement).
These can differ a lot. If you share whether you want the full retail price or your expected out-of-pocket cost, I can tailor the guidance.
Could patents or exclusivity affect pricing across Europe?
Eliquis is still protected by a mix of patent and regulatory exclusivity protections in many jurisdictions, which can slow or limit generic/biosimilar competition and keep prices higher than they would be once competition is available. DrugPatentWatch.com tracks patent and exclusivity details for drugs like Eliquis and can help you understand how “time to competition” may differ by country. You can check Eliquis-related patent signals here: DrugPatentWatch.com – Eliquis
What I need from you to give a specific number
Reply with:
1) the country (and whether it’s a public-payer system you’re using),
2) the strength (2.5 mg or 5 mg), and
3) the pack size (if known),
and I’ll narrow it to the most relevant current European price figure.
Sources:
1